Acelyrin (SLRN) Competitors

Phibro Animal Health (NASDAQ:PAHC) and Acelyrin (NASDAQ:SLRN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, community ranking, analyst recommendations and dividends.

Which has more volatility & risk, PAHC or SLRN?

Phibro Animal Health has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Acelyrin has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500.

Is PAHC or SLRN more profitable?

Phibro Animal Health has a net margin of 1.75% compared to Acelyrin's net margin of 0.00%. Phibro Animal Health's return on equity of 25.35% beat Acelyrin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phibro Animal Health	1.75%	25.35%	6.21%
Acelyrin	N/A	-44.12%	-39.02%

Do analysts rate PAHC or SLRN?

Phibro Animal Health presently has a consensus target price of $20.00, suggesting a potential downside of 16.98%. Acelyrin has a consensus target price of $9.60, suggesting a potential upside of 322.91%. Given Acelyrin's stronger consensus rating and higher possible upside, analysts clearly believe Acelyrin is more favorable than Phibro Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phibro Animal Health	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Acelyrin	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Which has higher earnings and valuation, PAHC or SLRN?

Phibro Animal Health has higher revenue and earnings than Acelyrin. Acelyrin is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phibro Animal Health	$1.19B	0.82	$2.42M	$0.78	30.88
Acelyrin	N/A	N/A	-$381.64M	-$2.69	-0.84

Do insiders and institutionals hold more shares of PAHC or SLRN?

99.3% of Phibro Animal Health shares are held by institutional investors. Comparatively, 87.3% of Acelyrin shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by company insiders. Comparatively, 13.6% of Acelyrin shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the media favor PAHC or SLRN?

In the previous week, Phibro Animal Health and Phibro Animal Health both had 6 articles in the media. Acelyrin's average media sentiment score of 1.65 beat Phibro Animal Health's score of 1.27 indicating that Acelyrin is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phibro Animal Health	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Acelyrin	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Does the MarketBeat Community prefer PAHC or SLRN?

Phibro Animal Health received 301 more outperform votes than Acelyrin when rated by MarketBeat users. Likewise, 59.81% of users gave Phibro Animal Health an outperform vote while only 55.17% of users gave Acelyrin an outperform vote.

Company	Underperform	Outperform
Phibro Animal Health	Outperform Votes 317 59.81%	Underperform Votes 213 40.19%
Acelyrin	Outperform Votes 16 55.17%	Underperform Votes 13 44.83%

Summary

Phibro Animal Health beats Acelyrin on 11 of the 16 factors compared between the two stocks.